Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
XSpray Pharma AB's Total Assets for the quarter that ended in Mar. 2026 was kr736.39 Mil.
During the past 12 months, XSpray Pharma AB's average Total Assets Growth Rate was 0.60% per year.
During the past 3 years, the average Total Assets Growth Rate was 9.80% per year.
During the past 5 years, the average Total Assets Growth Rate was 17.80% per year.
During the past 10 years, the average Total Assets Growth Rate was 58.90% per year.
During the past 11 years, XSpray Pharma AB's highest 3-Year average Total Assets Growth Rate was 211.80%. The lowest was 9.80%. And the median was 44.85%.
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
XSpray Pharma AB's Asset Turnover for the quarter that ended in Mar. 2026 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
XSpray Pharma AB Total Assets Related Terms
XSpray Pharma AB Total Assets Historical Data
* Premium members only.
The historical data trend for XSpray Pharma AB's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
XSpray Pharma AB's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSpray Pharma AB (OSTO:XSPRAY) has a Total Assets of kr736.39 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on XSpray Pharma AB and its competitors.
Is XSpray Pharma AB's Total Assets too high?
XSpray Pharma AB's current Total Assets is kr736.39 Mil. Overall, XSpray Pharma AB has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does XSpray Pharma AB's Total Assets compare to VRTX and REGN?
XSpray Pharma AB's Total Assets of kr736.39 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on XSpray Pharma AB and its competitors. XSpray Pharma AB's current Total Assets is kr736.39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XSpray Pharma AB stock overvalued right now?
XSpray Pharma AB (OSTO:XSPRAY) has a current Total Assets of kr736.39 Mil. The current Total Assets is kr736.39 Mil. XSpray Pharma AB's overall GF Score™ is 29/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For XSpray Pharma AB (OSTO:XSPRAY), the current Total Assets is kr736.39 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
XSpray Pharma AB is a pharmaceutical company focused on developing improved PKIs for cancer treatment, leveraging its proprietary HyNap technology platform. The company aims to enhance clinical outcomes for cancer patients by improving the efficacy, safety, and patient experience of existing cancer therapies. Its product portfolio includes Dasynoc and other product candidates in different stages of development such as XS003 nilotinib, XS008 axitinib, and other.
29GF Score
Get the complete analysis for OSTO:XSPRAY
Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:XSPRAY has been successfully added to your 
